Please try another search
NeuBase Therapeutics, Inc. is a preclinical-stage biopharmaceutical company. The Company is developing a modular peptide-nucleic acid (PNA) antisense oligo (PATrOL) platform to address genetic diseases. The PATrOL-enabled anti-gene therapies are designed to improve upon current genetic medicine strategies by combining the advantages of synthetic approaches with the precision of antisense technologies. Its programs are NT-0100 in HD, NT-0200 in Myotonic Dystrophy Type 1 (DM1) and NT-0300 in KRAS-driven cancers. The NT-0100 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the HD messenger ribonucleic acid (mRNA). The NT-0200 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the DM1 disease mRNA. The NT-0300 program is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene.
Name | Age | Since | Title |
---|---|---|---|
Robert Zamboni | - | - | Chief of Preclinical Development & Member of Scientific Advisory Board |
Dov A. Goldstein | 55 | 2019 | Independent Chairperson |
Eric I. Richman | 62 | 2019 | Independent Director |
Robert Friedlander | - | - | Chair of Scientific Advisory Board |
George McDonald Church | 69 | 2023 | Chairperson of Gene Editing Advisory Board & Member of Scientific Advisory Board |
Peter Nielsen | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Randy Davis | - | 2020 | Member of Scientific Advisory Board |
Eriks Rozners | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Gerald J. Mcdougall | 56 | 2021 | Independent Director |
Danith H. Ly | - | 2019 | Member of Advisory Board |
Steven F. Dowdy | - | 2019 | Member of Gene Editing & Scientific Advisory Board |
James M. Coull | - | 2023 | Member of Gene Editing Advisory Board |
Jeremy Stark | - | 2023 | Member of Gene Editing Advisory Board |
Dietrich A. Stephan | 54 | 2019 | Founder, President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review